Sequence coverage of the heavy chain and light chain of originator... | Download Scientific Diagram
Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy - ScienceDirect
Unravelling the potentialities of tocilizumab for the development of a potential immunotherapeutic regimen against COVID-19—A narrative review
Anti-hIL-6R mAbs | Tocilizumab | InvivoGen
JCI - IL-6 polymorphisms: a useful genetic tool for inflammation research?
Tocilizumab: Uses, Interactions, Mechanism of Action | DrugBank Online
Interleukin-6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: A randomized controlled trial - American Journal of Transplantation
TropicalMed | Free Full-Text | Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation during Acute Respiratory Distress: A Case Report and Literature Review
The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy | Arthritis Research & Therapy | Full Text
761037Orig1s000
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine
Pharmaceutics | Free Full-Text | Effects of Tocilizumab on Inflammation and Iron Metabolism in Critically Ill Patients with COVID-19
Sequence coverage of the heavy chain and light chain of originator... | Download Scientific Diagram
Cureus | High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial | Article
Comparing the efficacy of tocilizumab with corticosteroid therapy in treating COVID-19 patients: a systematic review and meta-analysis | SpringerLink
Frontiers | Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group - eClinicalMedicine
JCM | Free Full-Text | The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies
![Rapid Evidence Review: Tocilizumab in the management of patients who have severe COVID-19 infection with suspected hyperinflammation. [v6.0]](https://www.lenus.ie/bitstream/handle/10147/628004/COVID-19_Evidence_Review_Group_Tocilizumab_V6_Final_Version.pdf.jpg?sequence=8&isAllowed=y "Rapid Evidence Review: Tocilizumab in the management of patients who have severe COVID-19 infection with suspected hyperinflammation. [v6.0]")
Rapid Evidence Review: Tocilizumab in the management of patients who have severe COVID-19 infection with suspected hyperinflammation. [v6.0]
Frontiers | Tocilizumab and COVID-19: Timing of Administration and Efficacy
Physicochemical and Biological Characterization of the Proposed Biosimilar Tocilizumab - Document - Gale OneFile: Health and Medicine
